Frontiers
US$ 28.25
exendin-4 glp-1 (GLP-1 Analog) 1JRJ – Biologic Models Exendin-4 gene modification and microscaffold
Description
To evaluate the observed response, we measured cAMP from sinus node superfusates collected right before and 15 min after GLP-1 exposure, as well as in supernatants from sinus nodes statically incubated with or without GLP-1 for 30 min
That matters for both competitive positioning and manufacturing strategy
The honest framing is that they are not interchangeable, and the decision should be based on the patients full clinical picture rather than the headline number alone
For most patients, GLP-1 agonists represent safe and effective treatment options
however, dulaglutide had a neutral effect on HF hospitalisation
